Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Yoshimura

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Molecular and Clinical Oncology|June 23, 2016
Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemiaYoshiko Azuma, Aya Nakaya, Masaaki Hotta, et al.
International Medical Case Reports Journal|June 12, 2013
Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantationRyotaro Ozasa, Masaaki Hotta, Hideaki Yoshimura, et al.
Hematology Reports|October 5, 2018
Clinical significance of dasatinib-induced pleural effusion in patients with de <i>novo</i> chronic myeloid leukemiaAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Chemical Communications (Cambridge, England)|November 2, 2011
Halichonines A, B, and C, novel sesquiterpene alkaloids from the marine sponge Halichondria okadai KadotaOsamu Ohno, Tatsuhiko Chiba, Seiji Todoroki, et al.
Hematology Reports|March 14, 2017
Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent EraAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Acta Haematologica|July 21, 2017
Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World ExperienceAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Molecular and Clinical Oncology|February 20, 2016
Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case reportYukie Fujita, Aya Nakaya, Shinya Fujita, et al.
Clinical Case Reports|December 12, 2017
Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case reportYuki Takeyasu, Atsushi Satake, Yoshiko Azuma, et al.
International Journal of Hematology|August 31, 2016
Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two casesYukie Tsubokura, Atsushi Satake, Masaaki Hotta, et al.
Leukemia Research|September 26, 2016
Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?Aya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Molecular and Clinical Oncology|June 23, 2016
Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemiaYoshiko Azuma, Aya Nakaya, Masaaki Hotta, et al.
International Medical Case Reports Journal|June 12, 2013
Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantationRyotaro Ozasa, Masaaki Hotta, Hideaki Yoshimura, et al.
Hematology Reports|October 5, 2018
Clinical significance of dasatinib-induced pleural effusion in patients with de <i>novo</i> chronic myeloid leukemiaAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Chemical Communications (Cambridge, England)|November 2, 2011
Halichonines A, B, and C, novel sesquiterpene alkaloids from the marine sponge Halichondria okadai KadotaOsamu Ohno, Tatsuhiko Chiba, Seiji Todoroki, et al.
Hematology Reports|March 14, 2017
Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent EraAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Acta Haematologica|July 21, 2017
Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World ExperienceAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Molecular and Clinical Oncology|February 20, 2016
Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case reportYukie Fujita, Aya Nakaya, Shinya Fujita, et al.
Clinical Case Reports|December 12, 2017
Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case reportYuki Takeyasu, Atsushi Satake, Yoshiko Azuma, et al.
International Journal of Hematology|August 31, 2016
Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two casesYukie Tsubokura, Atsushi Satake, Masaaki Hotta, et al.
Leukemia Research|September 26, 2016
Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?Aya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Pageof 9